FDA Will Follow The Science On COVID-19 Vaccines For Young Children
As schools around the country are re-opening for in-person learning and families are returning to their busy school year schedules, we know many parents...
How To Help Your Dear One Recover From Their Addiction
Addiction can be a difficult journey to help your dear one recover from. As a family member, you are in one of the most...
FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products...
As required by statute, a key consideration in their review of premarket tobacco product applications submitted for products like e-cigarettes is to determine whether permitting the marketing of the product would be "appropriate for the protection of the public health," taking into account the risks and benefits to the population as a whole.
OrthAlign Announces Clinical Milestone Having Performed 200,000 Joint Arthroplasty Cases Worldwide
Eric Timko, Chairman and CEO of OrthAlign Inc. "This has been an exciting journey for OrthAlign and with the launch underway of our next generation flagship product, Lantern, we expect our strong momentum to continue.
Results of a Dual-Site Study Involving the Non-Invasive vMap System™ During SAbR Published In Heart Rhythm O2
An article published by the Heart Rhythm Society’s journal Heart Rhythm O2 concludes that Vektor’s Computational ECG Mapping System (vMap™) and protocol-based respiratory gating may help facilitate radioablation planning and maintain efficacy during therapy.